Outlook Therapeutics OTLK
Outlook Therapeutics: quarterly report for the quarter ended Dec 31, 2021
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001558370-22-001128
- Document
- 10-Q
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- OnKure Therapeutics OKUR public float $28M, Jun 30, 2025
- Palatin Technologies PTN public float $26M, Dec 31, 2025
- Scynexis SCYX public float $26M, Jun 30, 2025
- Champions Oncology CSBR public float $29M, Oct 31, 2025
- Rockwell Medical RMTI public float $29M, Jun 30, 2025